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Objective
Bardet-Biedl syndrome (BBS) is a rare disease character-
ized by a high genetic heterogeneity, accounting for 75%
of affected families. As part of the next-generation tech-
nology, whole-exome sequencing (WES) allows all exons
of the genome to be sequenced at once. Here we show
the use of WES as a useful approach in BBS families in
which mutations in predominant genes have been
discarded.
Methods
We studied the exome of 15 unrelated patients clinically
diagnosed with BBS. For this purpose, we used the
Nimblegen SeqCap v3 (64Mb) kit for exome capture,
followed by the use of Illumina HiSeq 2000 sequencer,
with a mean coverage per sample >50X. Once the
sequencing data alignment and variant calling were
made, we carried out a filtering strategy to identify can-
didate mutations responsible for the disorder, which
need to be confirmed by direct sequencing. Segregation
analyses were performed when possible.
Results
This approach, focused on evaluating mutations in genes
involved in the pathology (all BBS genes, and also
ALMS1 gene), has allowed us to diagnose 4 families,
identifying 5 potential disease-causing mutations repre-
senting 3 different known genes (BBS2, BBS5 and
ALMS1). 4 of these changes were novel mutations and
segregation studies confirmed the carrier state in parents.
In the remaining families, we have selected some candi-
date genes which are under evaluation.
Conclusion
We consider this is a good and economically worthwhile
strategy when predominant mutations have been dis-
carded in the analysed population. Moreover, it allows
us to reduce diagnostic time and offers the possibility to
identify novel candidate genes.
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